4592 SanBio Company Limited - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4592

TSE Growth

SanBio Company Limited

1,907

JPY

-70

(-3.54%)

Apr 30, 11:19 am JST

11.89

USD

Apr 29, 10:19 pm EDT

Result

PTS

outside of trading hours

1,906.6

Apr 30, 11:19 am JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan, 2023	0	-7,899	-4,698	-5,559	-96.0	0	Mar 16, 2023	J-GAAP
Jan, 2024	0	-4,539	-2,824	-2,644	-40.5	0	Mar 18, 2024	J-GAAP
Jan, 2025	0	-3,516	-3,022	-2,882	-41.9	0	Mar 17, 2025	J-GAAP
Jan, 2026	0	-3,794	-4,291	-3,842	-52.6	0	Mar 17, 2026	J-GAAP
Jan, 2027 Guidance	ー	-5,625	-5,632	-5,635	-72.2	0	Mar 17, 2026	J-GAAP
YoY	－	-48.3%	-31.3%	-46.7%	-37.4%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jan, 2022	Mar 17, 2021	ー	-5,786	-5,876	-5,877	0	J-GAAP
-	Feb 10, 2022	ー	-6,589	-4,545	-4,645	0	J-GAAP
- Results	Mar 11, 2022	0	-6,620	-4,579	-4,677	0	J-GAAP
Jan, 2023	Mar 11, 2022	Available in future release
	Sep 14, 2022
Results	Mar 16, 2023
Jan, 2024	Mar 16, 2023
Results	Mar 18, 2024
Jan, 2025	Mar 18, 2024
	Feb 4, 2025
Results	Mar 17, 2025
Jan, 2026	Mar 17, 2025
	Sep 12, 2025
Results	Mar 17, 2026
Jan, 2027	Mar 17, 2026	ー	-5,625	-5,632	-5,635	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan, 2014	204	－	Available in future release
Jan, 2015	3,229	+1,482.8
Jan, 2016	1,174	-63.6
Jan, 2017	949	-19.2
Jan, 2018	490	-48.4
Jan, 2019	741	+51.2
Jan, 2020	447	-39.7
Jan, 2021	0	-100.0
Jan, 2022	0	－
Jan, 2023	0	－
Jan, 2024	0	－
Jan, 2025	0	－
Jan, 2026	0	－
Jan, 2027 Guidance	ー	－	-5,625	-48.3	-5,632	-31.3	-72.2	-37.3

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Jan, 2025	0	-3,516	ー	-139.19	-67.86	ー	-41.9
Jan, 2026	0	-3,794	ー	-51.59	-40.30	ー	-52.6
Jan, 2027 Guidance	ー	-5,625	ー	-42.25	-36.07	ー	-72.2

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	3,229	2,248	2,228	1,736	44.3
Fiscal Year	Jan, 2015	Jan, 2015	Jan, 2015	Jan, 2015	Jan, 2015

First Half

Result

Guidance History

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb - Jul, 2023	0	-3,084	-1,930	-1,787	-27.6	0	Sep 14, 2023	J-GAAP
Feb - Jul, 2024	0	-1,571	-1,186	-1,309	-19.1	0	Sep 17, 2024	J-GAAP
Feb - Jul, 2025	0	-1,888	-2,481	-1,997	-27.8	0	Sep 12, 2025	J-GAAP
Feb - Jul, 2026 Guidance	ー	-2,906	-2,908	-2,909	-37.3	0	Mar 17, 2026	J-GAAP
YoY	－	-53.9%	-17.2%	-45.7%	-34.1%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jul, 2023	Mar 16, 2023	ー	-2,398	-2,341	-2,344	0	J-GAAP
- Results	Sep 14, 2023	0	-3,084	-1,930	-1,787	0	J-GAAP
Jul, 2024	Mar 18, 2024	Available in future release
Results	Sep 17, 2024
Jul, 2025	Mar 17, 2025
Results	Sep 12, 2025
Jul, 2026	Mar 17, 2026	ー	-2,906	-2,908	-2,909	0	J-GAAP

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Jan, 2024	-4,539	-4,784	-4,765	-19	2,370	4,389	86.96	J-GAAP
Jan, 2025	-3,516	-3,607	-3,603	-4	2,091	2,853	82.77	J-GAAP
Jan, 2026	-3,794	-3,991	-3,760	-231	15,962	14,815	94.84	J-GAAP

Actual Performance and Financial Trends

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan, 2024	0	-4,539	-2,824	-2,644	-40.5	0	Mar 18, 2024	J-GAAP
Jan, 2025	0	-3,516	-3,022	-2,882	-41.9	0	Mar 17, 2025	J-GAAP
Jan, 2026	0	-3,794	-4,291	-3,842	-52.6	0	Mar 17, 2026	J-GAAP
YoY	－	-7.9%	-42.0%	-33.3%	-25.5%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Feb - Apr, 2024	0	-666	91	-144	-2.1	-Inf	Jun 13, 2024	J-GAAP
May - Jul, 2024	0	-905	-1,277	-1,165	-17.0	-Inf	Sep 17, 2024	J-GAAP
Aug - Oct, 2024	0	-911	-813	-843	-12.3	-Inf	Dec 16, 2024	J-GAAP
Nov - Jan, 2024	0	-1,034	-1,023	-730	-10.6	-Inf	Mar 17, 2025	J-GAAP
Feb - Apr, 2025	0	-1,007	-1,750	-1,531	-21.4	-Inf	Jun 13, 2025	J-GAAP
May - Jul, 2025	0	-881	-731	-466	-6.5	-Inf	Sep 12, 2025	J-GAAP
Aug - Oct, 2025	0	-785	-678	-716	-10.0	-Inf	Dec 15, 2025	J-GAAP
Nov - Jan, 2025	0	-1,121	-1,132	-1,129	-15.4	-Inf	Mar 17, 2026	J-GAAP
YoY	－	-8.4%	-10.7%	-54.7%	-45.7%

Fiscal Year	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Feb - Apr, 2021	－	Available in future release
May - Jul, 2021	－
Aug - Oct, 2021	－
Nov - Jan, 2021	－
Feb - Apr, 2022	－
May - Jul, 2022	－
Aug - Oct, 2022	－
Nov - Jan, 2022	－
Feb - Apr, 2023	－
May - Jul, 2023	－
Aug - Oct, 2023	－
Nov - Jan, 2023	－
Feb - Apr, 2024	－
May - Jul, 2024	－
Aug - Oct, 2024	－
Nov - Jan, 2024	－
Feb - Apr, 2025	－
May - Jul, 2025	－
Aug - Oct, 2025	－
Nov - Jan, 2025	－	-1,121	-8.4	-1,132	-10.7	-15.4	-45.3

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	688	77	1,211	1,456	28.1
Fiscal Year	Oct, 2015	Apr, 2016	Oct, 2022	Jan, 2020	Jan, 2020

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Jan, 2024	38.08	51.2	5,047	2,586	-1,950	0.26	Mar 18, 2024	J-GAAP
Jan, 2025	21.93	45.1	3,447	1,555	-698	0.26	Mar 17, 2025	J-GAAP
Jan, 2026	170.93	85.4	15,621	13,338	-995	0.09	Mar 17, 2026	J-GAAP

SanBio Company Limited(4592) Financial Results